Neidio i'r cynnwys

Pfizer–BioNTech COVID-19 vaccine

Ni chefnogir cynnwys y dudalen mewn ieithoedd eraill.
Creu erthygl

This is an automatic view based on data from Wicidata.
There is not a complete article yet, but you can help creating one.

mRNA vaccine against COVID-19 from BioNTech in cooperation with Pfizer

Adnoddau allanol

WikiProjectMed ID
Pfizer–BioNTech COVID-19 vaccine
dynodwr MeSH
D000090982

enwyd fel: BNT162 Vaccine

Cod MeSH
D12.776.828.868.228.500.750
D20.215.894.865.450.500.750
D20.215.894.899.085.500
D23.050.865.450.500.750
UNII
5085ZFP6SJ
Rhif Cofrestru CAS
2417899-77-3
Australian Register of Therapeutic Goods ID
346290
Cod yr ATC
J07BX[1]
PubChem Substance ID (SID)
434370509
dynodwr VIOLIN
5784
World Health Organisation international non-proprietary name numeric ID
11889
European Medicines Agency product number
EMEA/H/C/005735[1]
dynodwr Google Knowledge Graph
/g/11lgrt_kcf
MedlinePlus drug identifier
a621003
RxNorm ID
2468230
Dynodwr Drugbank (Alberta)
DB15696
Vaccine Ontology ID
VO_0004987

enghraifft o'r canlynol

funded product[2]

isddosbarth o'r canlynol

COVID-19 vaccine
RNA vaccine

funder

Cabinet Gweriniaeth Ffederal yr Almaen[3]

World Health Organisation international non-proprietary name

tozinameran[4][5]
tozinameranum[4][5]
tozinaméran[4][5]
tozinamerán[4][5]
tozinameran
توزيناميران[5]
тозинамеран[6]
托兹奈米瑞[6]

brechlyn ar gyfer

COVID-19[2]

side effect

anaffylacsis[7][8]

natur y datganiad: yn anaml

dull gweini

pigiad mewngyhyrol[9]

gwneuthurwr

Pfizer[2][10]

yn perthyn i'r awdurdod canlynol: Unol Daleithiau America

Rentschler Biopharma SE[11]
Behringwerke[12][13]

dyddiad neu amser cychwyn: Medi 2020

BioNTech

yn perthyn i'r awdurdod canlynol: yr Undeb Ewropeaidd

Baxter International[14]

dyddiad cyrchiad: 4 Mai 2021

datblygwr

BioNTech[2]
Pfizer[15]

disgrifiwyd gan y ffynhonnell

Study to Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults[16]
Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report[17]
Concurrent human antibody and TH1 type T-cell responses elicited by a COVID-19 RNA vaccine[18]
A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults[19]
Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults[20]
RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study[20]
A Phase I clinical trial of novel coronavirus pneumonia (COVID-19) mRNA Vaccine (BNT162b1) in China[19]
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates[18]

price

20 $ (UDA)[21]

pwynt mewn amser: 15 Rhagfyr 2020

12 Ewro[22]

pwynt mewn amser: 17 Rhagfyr 2020

Thesawrws NCI

C173055

categori Comin

Tozinameran

Cyfeiriadau

  1. ↑ 1.0 1.1 European Medicines Agency, 24 Rhagfyr 2020, https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty, EMEA/H/C/005735
  2. ↑ 2.0 2.1 2.2 2.3 11 Gorffennaf 2020, https://covid-19tracker.milkeninstitute.org/
  3. ↑ https://www.reuters.com/article/idUSKBN2661JB
  4. ↑ 4.0 4.1 4.2 4.3 WHO Drug Information, https://www.who.int/medicines/publications/druginformation/issues/DrugInformation2020_Vol34-3/en/, 641–685, 3, Saesneg, 23 Hydref 2020, List No. 124 – COVID-19 (Special Edition) of Proposed International Nonproprietary Names (INN) for Pharmaceutical Substances, 34
  5. ↑ 5.0 5.1 5.2 5.3 5.4 International nonproprietary name, 11889, 20 Chwefror 2021, https://mednet-communities.net/inn/db/ViewINN.aspx?i=11889
  6. ↑ 6.0 6.1 11889
  7. ↑ https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/anaphylaxis-management.html
  8. ↑ Suspicions grow that nanoparticles in Pfizer’s COVID-19 vaccine trigger rare allergic reactions
  9. ↑ https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/pfizer-specific-training_full-deck_19aug.pdf
  10. ↑ https://www.pfizer.com/products/product-list
  11. ↑ https://covid-19tracker.milkeninstitute.org/, 12 Tachwedd 2020
  12. ↑ https://www.zeit.de/2020/47/biontech-corona-impfstoff-start-up-pandemie, 12 Tachwedd 2020
  13. ↑ https://www.aerztezeitung.de/Wirtschaft/In-Marburg-statt-Grippe-Vazine-bald-Produktion-von-Corona-Impfstoff-412953.html, 12 Tachwedd 2020
  14. ↑ https://www.reuters.com/article/us-health-coronavirus-vaccines-baxter-in-idUSKBN29I18Y
  15. ↑ https://www.who.int/publications/i/item/background-document-on-mrna-vaccine-bnt162b2-(pfizer-biontech)-against-covid-19, 4 Mai 2021
  16. ↑ 12 Gorffennaf 2020, https://covid-19tracker.milkeninstitute.org/
  17. ↑ 26 Awst 2020, https://covid-19tracker.milkeninstitute.org/
  18. ↑ 18.0 18.1 inferred from abstract
  19. ↑ 19.0 19.1 https://covid-19tracker.milkeninstitute.org/, 30 Awst 2020
  20. ↑ 20.0 20.1 inferred from title
  21. ↑ aljazeera.com, https://www.aljazeera.com/news/2020/12/15/sputnik-v-what-to-know-about-the-russian-vaccine-in-500-words, Saesneg, 15 Rhagfyr 2020, Sputnik V: What to know about the Russian vaccine, in 500 words
  22. ↑ Politico Europe, https://www.politico.eu/article/belgian-secretary-of-state-accidentally-reveals-eu-vaccine-prices/, Saesneg, 17 Rhagfyr 2020, Belgian secretary of state accidentally reveals EU vaccine prices
Wedi dod o "https://cy.wikipedia.org/wiki/Arbennig:Am_y_Pwnc/Q97154240"